Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.26 USD | +0.61% | 0.00% | -23.06% |
17/04 | Morgan Stanley Trims Price Target on WalkMe to $11 From $12, Keeps Equalweight Rating | MT |
15/04 | Barclays Adjusts Price Target on WalkMe to $8.50 From $10, Maintains Underweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.06% | 75Cr | |
-3.48% | 886.89Cr | |
-4.72% | 468.42Cr | |
+2.13% | 50Cr | |
-11.34% | 44Cr | |
-7.71% | 28Cr | |
-26.49% | 22Cr | |
-44.02% | 18Cr | |
-8.22% | 15Cr | |
-13.35% | 14Cr |
- Stock Market
- Equities
- WKME Stock
- News WalkMe Ltd.
- BMO Capital Raises WalkMe's Price Target to $13 From $10.50, Maintains Outperform Rating